Loading...
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance
Breast Cancer Type 1 Susceptibility Protein (BRCA1)-deficient cells have compromised DNA repair and are sensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. Despite initial responses, the development of resistance limits clinical efficacy. Mutations in the BRCA C-terminal (BRCT) domain of BRC...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3801063/ https://ncbi.nlm.nih.gov/pubmed/24085845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1305170110 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|